Bio-Techne Corporation (TECH) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 11.36B USD. 52-week range 43.20 to 72.69 USD. Trailing P/E 62.5. Data as of 2026-10-09.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, ...